We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
Cap. Flow
+$161M
Cap. Flow %
6.13%
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$13.4M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$10.5M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$10M
4
MDCO
Medicines Co
MDCO
+$8.78M
5
TIF
Tiffany & Co.
TIF
+$7.91M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$42.5M
2
VSM
Versum Materials, Inc.
VSM
+$29.7M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$23.3M
4
AABA
Altaba Inc
AABA
+$18.8M
5
CPE
Callon Petroleum Company
CPE
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 4.59%
2 Healthcare 3.78%
3 Consumer Discretionary 3.06%
4 Communication Services 2.48%
5 Real Estate 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRUS
1801
DELISTED
Merus
MRUS
$3K ﹤0.01%
230
-94
-29% -$1.51K
NTRA icon
1802
Natera
NTRA
$46.4B
$3K ﹤0.01%
+92
New +$3.39K
OPTN
1803
DELISTED
OptiNose
OPTN
$3K ﹤0.01%
+20
New +$2.59K
PHR icon
1804
Phreesia
PHR
$773M
$3K ﹤0.01%
100
-1,600
-94% -$44.2K
STRO icon
1805
Sutro Biopharma
STRO
$421M
$3K ﹤0.01%
30
-101
-77% -$10.4K
TLRY icon
1806
Tilray
TLRY
$622M
$3K ﹤0.01%
20
+15
+300% +$3.1K
TXMD icon
1807
TherapeuticsMD
TXMD
$24M
$3K ﹤0.01%
28
-4
-13% -$575
UPWK icon
1808
Upwork
UPWK
$1.19B
$3K ﹤0.01%
300
-39,000
-99% -$491K
BEST
1809
PUT
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$3K ﹤0.01%
+25
New +$2.74K
VRAY
1810
DELISTED
ViewRay, Inc.
VRAY
$3K ﹤0.01%
+651
New +$2.1K
STML
1811
DELISTED
Stemline Therapeutics, Inc.
STML
$3K ﹤0.01%
322
+106
+49% +$1.05K
EFOR
1812
Everforth Inc
EFOR
$1.32B
$2K ﹤0.01%
+23
New +$1.5K
FENC icon
1813
Fennec Pharmaceuticals
FENC
$402M
$2K ﹤0.01%
244
-26
-10% -$140
MCHB
1814
Mechanics Bancorp
MCHB
$3.68B
$2K ﹤0.01%
+46
New +$1.42K
JNUG icon
1815
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$531M
$2K ﹤0.01%
2
– –
MJ icon
1816
CALL
Amplify Alternative Harvest ETF
MJ
$105M
$2K ﹤0.01%
+8
New +$1.76K
MTW icon
1817
Manitowoc
MTW
$675M
$2K ﹤0.01%
131
-1,060
-89% -$15.5K
PAYC icon
1818
Paycom
PAYC
$9.69B
$2K ﹤0.01%
7
-1,679
-100% -$397K
PRPL icon
1819
Purple Innovation
PRPL
$41.7M
$2K ﹤0.01%
+8
New +$1.54K
SAM icon
1820
Boston Beer
SAM
$1.92B
$2K ﹤0.01%
4
-115
-97% -$43.3K
SGMO
1821
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2K ﹤0.01%
276
-48
-15% -$441
SXC icon
1822
SunCoke Energy
SXC
$797M
$2K ﹤0.01%
352
-7,648
-96% -$42.5K
TRN icon
1823
PUT
Trinity Industries
TRN
$2.38B
$2K ﹤0.01%
100
– –
VYGR icon
1824
Voyager Therapeutics
VYGR
$201M
$2K ﹤0.01%
147
+39
+36% +$567
WAFD icon
1825
WaFd
WAFD
$2.75B
$2K ﹤0.01%
+48
New +$1.76K
71 72
73
74 75

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.

  • Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
  • Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
  • Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
  • Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
  • Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.